Affiliation:
1. Joint Implant Surgeons, 7277 Smith’s
Mill Road, Suite 200, New
Albany, Ohio 43054, USA.
Abstract
Over the past 30 years there have been many improvements in implant fixation, correction of deformity, improved polyethylene wear, and survival after knee replacement. The work over the last decade has focused on less invasive surgical techniques, multimodal pain management protocols, more rapid functional recovery and reduced length of stay, aiming to minimise the side effects of treatment while maintaining function and implant durability. When combined and standardised these pre-, intra- and post-operative factors have now facilitated outpatient knee replacement procedures for unicompartmental replacement, patella femoral arthroplasty and total knee replacement (TKR). We have found liposomal bupivacaine, with potential for longer therapeutic action, to be a helpful adjunct and describe our current pain management program. The next step in our multimodal program is to improve the duration of patient satisfaction and reduce cost and length of stay after TKR. Cite this article: Bone Joint J 2014;96-B(11 Suppl A):7–9.
Publisher
British Editorial Society of Bone & Joint Surgery
Subject
Orthopedics and Sports Medicine,Surgery
Reference7 articles.
1. Feasibility and safety of performing outpatient unicompartmental knee arthroplasty
2. Barrington JLiposomal bupivicaine: the first 1,000 cases in a new era. Paper 675, American Academy of Orthopaedic Surgeons, New Orleans, 2014.
3. Emerson RComparison of infiltration with long-acting bupivacaine to a femoral nerve catheter for total knee replacement. Poster 124, American Academy of Orthopaedic Surgeons, New Orleans, 2014.
4. Liposomal Bupivacaine Versus Traditional Periarticular Injection for Pain Control After Total Knee Arthroplasty
Cited by
64 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献